Alpha2* Nicotinic Acetylcholine Receptors as a Therapeutic Target for Memory Enhancement
Dr Katumi Sumikawa, University of California, speaking at Ion Channel Targets 2011.
Smooth Muscle Kv7 (KCNQ) Potassium Channels: Important New Therapeutic Targets
Professor Kenneth Byron, Loyola University Chigaco, speaking at Ion Channel Targets 2011.
A Systematic Investigation of Candidate Breast Cancer Progression-Associated Biomarkers Identified from Omic Screens: Leveraging Antibody-Based Proteomics
Prof. William Gallagher, Chief Scientific Officer at OncoMark, speaking at Advances in Microarray Technology 2011.
3D-Gel Electrophoresis, a New Development in Protein Analysis
Robert Ventzki, University of Greifswald, speaking at Advances in Separation Technology 2011.
Quantitative Proteomics For Biomarker Discovery and Validation: Prostate Cancer Case Study
Stephen Pennington, UCD Dublin, Professor of Proteomics, speaking at European Biomarkers Summit 2011.
Genome-scale Quantitative Tumour Proteomics for Cancer Biomarkers Discovery
Metodi Metodiev, Lecturer/Director of Proteomics Unit, University of Essex, speaking at European Biomarkers Summit 2011.
Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics Technologies
Andreas Jenne, CEO, Kinaxo, speaking at European Biomarkers Summit 2011.
Development of a Blood Based Molecular Test to Aid in the Diagnosis of Schizophrenia
Emanuel Schwarz, Post Doctoral Researcher, University of Cambridge, speaking at European Biomarkers Summit 2011.
Pharmacogenomics of Drug Disposition: From Polymorphisms to Biomarkers
Urs A. Meyer, Emeritus Professor, Biozentrum, University of Basel speaking at ADMET Europe 2011